Invokana Diabetic Ketoacidosis Lawsuit

Invokana Diabetic Ketoacidosis Lawsuit. Johnson & Johnson the world’s largest pharmaceutical and medical device maker and it’s Janssen subsidiary are exposed to serious allegations that the companies failed to warn about severe side effects from its blockbuster line of new diabetic drugs.

Invokana Diabetic Ketoacidosis Lawsuit

According to Karyn Norris in her product liability lawsuit, the diabetes drug Invokana caused her to be hospitalized with severe diabetic ketoacidosis.

What is Diabetic ketoacidosis?

Diabetic ketoacidosis is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones.

This severe condition develops when your body can’t produce enough insulin. Without enough insulin, your body begins to break down fat as fuel. This process causes a buildup of acids in the bloodstream called ketones, leading to diabetic ketoacidosis if untreated.

Norris claims that she was prescribed Invokana in June 2014. But within several months of Invokana use, she developed severe diabetic ketoacidosis, which led to her hospitalization.

What is Invokana?

Invokana also known as canagliflozin was approved in 2013, as the first member of a new class of diabetes drugs, known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.

SGLT2 inhibitors act in a unique way by releasing more glucose or sugar into the urine. Other SGLT2 inhibitors include Invokamet, Jardiance, Farxiga, and Xigduo to name a few.

Over the last few years, many diabetic patients have switched to Invokana, from other diabetic medications such as Avandia (linked to cardiovascular side effects) and Actos (linked to bladder cancer) because of deadly side effects.

Now Invokana side effects have been discovered including Invokana amputation risks, diabetic ketoacidosis, kidney failure, heart attacks and other catastrophic injuries.

FDA Invokana Diabetic Ketoacidosis Warnings

In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, highlighting that the medication significantly increases the risk of this potentially deadly condition.

Patients were advised by the FDA to stop taking Invokana and seek medical attention immediately if they have any symptoms of ketoacidosis, a condition when the body produces high levels of blood acids called ketones.

In June 2016, the FDA required additional label warnings about the link between Invokana and kidney risks, highlighting that the medication may increase the risk of acute kidney injury.

FDA Warns about Invokana Amputation Risk

The FDA in May 2017 concluded that Invokana, Invokamet, Invokamet XR caused an increased risk of leg and foot amputations.

The FDA is requiring new warnings, including their most prominent Boxed Warning, to be added to the Invokana drug labels to describe this risk.

As patients become aware of the amputee side effects, injured patients are filing product liability lawsuits that claim that Invokana directly caused the amputation of their leg, foot or toes.

Invokana Personal Injury Litigation

Since December 2016, all federally-filed Invokana Diabetes Injury Lawsuits have been consolidated as part of the federal Invokana multidistrict litigation (MDL), which is centralized before U.S. District Judge Brian Martinotti in the District of New Jersey to coordinate discovery and pretrial proceedings.

If you or someone you know succumbed to an Invokana Ketoacidosis, leg, foot, toes amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr. Shezad Malik Law Firm based in Dallas, Texas is investigating Invokana Ketoacidosis, leg amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes.